Jump to content

Talk:Mitochondrial permeability transition pore

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by Cewbot (talk | contribs) at 07:53, 6 February 2024 (Maintain {{WPBS}} and vital articles: 2 WikiProject templates. Create {{WPBS}}. Keep majority rating "Start" in {{WPBS}}. Remove 2 same ratings as {{WPBS}} in {{WikiProject Physiology}}, {{WikiProject Molecular Biology}}. Remove 1 deprecated parameter: auto.). The present address (URL) is a permanent link to this version.
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Untitled

[edit]

I was thinking of making an article for mitochondrial permeability transition (which currently redirects here). Should it be a subsection of this page, or should it get an article on its own? delldot | talk 18:46, 15 July 2006 (UTC)[reply]

No responses so I went ahead and moved the article. Let me know here if there's any problem with this. delldot | talk 05:04, 2 January 2007 (UTC)[reply]

Importance in Heart

[edit]

This (MPT pore) and administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) seem to have important uses (research) in heart failure models. Could someone develop a section explaining this and the relationship of the pore to the administration of the drug -- particular in the heart? 148.177.1.211 (talk) 17:13, 16 January 2015 (UTC)[reply]